Protagonist Therapeutics Inc Stock Performance
as on December 23, 2025 at 2:29 am IST
Day's Low
Day's High
$84.88$88.13
2.99%
Downside
0.72%
Upside
52 Week's Low
52 Week's High
$33.7$96.5461.49%
Downside
10.33%
Upside
Protagonist Therapeutics Inc share price movements today
- Previous Close
- $86.05
- Open
- $85.33
- Volume
- 802.9K
- Day's Low - High
- $84.88 - $88.13
- 52 Week Low - High
- $33.7 - $96.54
Protagonist Therapeutics Inc Historical Returns
- 1 Month Return
- + 0.76 %
- 3 Month Return
- + 33.39 %
- 1 Year Return
- + 107.4 %
- 3 Year Return
- + 777.17 %
- 5 Year Return
- + 242.42 %
Protagonist Therapeutics Inc Stock Fundamentals & Key Indicators
Check Protagonist Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.4B
EPS (TTM)
-1.8711
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
3.51%
PE Ratio (TTM)
130.38
Industry PE ratio
7.725789473684211
PEG Ratio
0EBITDA
20.0M
Revenue (TTM)
209.2M
Profit Margin
21.94%
Return On Equity TTM
7.80%
Protagonist Therapeutics Inc Stock Valuation
Track how Protagonist Therapeutics Inc P/E has moved over time to understand its valuation trends.
Protagonist Therapeutics Inc in the last 5 years
Lowest (-17.69x)
September 30, 2021
Industry (7.73x)
December 22, 2025
Today (130.38x)
December 22, 2025
Highest (91.67x)
September 30, 2025
Today’s Price to Earnings Ratio: 130.38x
Protagonist Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Protagonist Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $5.4B | 242.42% | 130.38 | 21.94% | |
| BUY | $37.3B | 385.94% | -16.34 | -264.83% | |
| BUY | $52.9B | 189.37% | 1429.39 | 1.36% | |
| BUY | $117.0B | 94.21% | 32.15 | 31.35% | |
| BUY | $81.4B | 56.71% | 18.42 | 32.13% |
Stock Returns calculator for Protagonist Therapeutics Inc Stock including INR - Dollar returns
The Protagonist Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Protagonist Therapeutics Inc investment value today
Current value as on today
₹2,16,316
Returns
₹1,16,316
(+116.32%)
Returns from Protagonist Therapeutics Inc Stock
₹1,10,894 (+110.89%)
Dollar Returns*
₹5,422 (+5.42%)
Analyst Recommendation on Protagonist Therapeutics Inc Stock
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Protagonist Therapeutics Inc. Average target price of $94.5
Protagonist Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Protagonist Therapeutics Inc.
What analysts predicted
7.41%UPSIDE
Target Price
$94.5
Current Price
$87.5
Analyzed by
12 Analysts
Target
$94.50
Protagonist Therapeutics Inc target price $94.5, a slight upside of 7.41% compared to current price of $87.5. According to 12 analysts rating.
Protagonist Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Protagonist Therapeutics Inc Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:7% versus previous 30 day period
Protagonist Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Protagonist Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Protagonist Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Protagonist Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Protagonist Therapeutics Inc News & Key Events
Today's Timeline - 13 October
Mon, 07:35 PM
-Johnson & Johnson reportedly in talks to acquire Protagonist Therapeutics, enhancing their collaboration on immunology treatments.
Insights on Protagonist Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, PTGX stock has moved up by 32.3%
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 803.6% return, outperforming this stock by 50.8%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 147.7% return, outperforming this stock by 35.8%
About Protagonist Therapeutics Inc
| Organisation | Protagonist Therapeutics Inc |
| Headquarters | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
| Industry | Health Technology |
| CEO | Dr. Dinesh V. Patel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Protagonist Therapeutics Inc
Name | Title |
|---|---|
Dr. Suneel K. Gupta Ph.D. | Executive Vice President of Clinical Development |
Dr. Arturo M. Molina FACP, M.D., M.S. | Chief Medical Officer |
Dr. Newman Yeilding | Executive VP, Chief Scientific Officer |
Ms. Carena Spivey | Senior VP & Chief Human Resources Officer |
Dr. Ashok Bhandari Ph.D. | EVP & Chief Discovery Officer |
Dr. Dinesh V. Patel Ph.D. | CEO, President, Secretary & Director |
Mr. Asif Ali | Executive VP & CFO |
Mr. Mohammad Masjedizadeh Ph.D. | Executive VP & CTO |
Mr. Matthew M. Gosling J.D. | Executive VP and Chief Legal & Business Officer |
Mr. Carter J. King | Executive Vice President of Business Development |
FAQs
What is Protagonist Therapeutics Inc share price today?
Protagonist Therapeutics Inc share price today is $87.5 as on at the close of the market. Protagonist Therapeutics Inc share today touched a day high of $88.13 and a low of $84.88.
What is the 52 week high and 52 week low for Protagonist Therapeutics Inc share?
Protagonist Therapeutics Inc share touched a 52 week high of $96.54 on and a 52 week low of $33.7 on . Protagonist Therapeutics Inc stock price today i.e. is closed at $87.5,which is 9.36% down from its 52 week high and 159.64% up from its 52 week low.
What is Protagonist Therapeutics Inc's market capitalisation today?
Protagonist Therapeutics Inc market capitalisation is $0.01T as on .
How to invest in Protagonist Therapeutics Inc Stock (PTGX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Protagonist Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protagonist Therapeutics Inc Shares that will get you 0.0171 shares as per Protagonist Therapeutics Inc share price of $87.5 per share as on December 23, 2025 at 2:29 am IST.
What is the minimum amount required to buy Protagonist Therapeutics Inc Stock (PTGX) from India?
Indian investors can start investing in Protagonist Therapeutics Inc (PTGX) shares with as little as ₹89.714 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹897.14 in Protagonist Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Protagonist Therapeutics Inc share’s latest price of $87.5 as on December 23, 2025 at 2:29 am IST, you will get 0.1143 shares of Protagonist Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Protagonist Therapeutics Inc has given to Indian investors in the last 5 years?
Protagonist Therapeutics Inc stock has given 242.42% share price returns and 21.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?